Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder: II. Identification of the cellular target structures by …

S Paulie, H Koho, H Ben-Aissa, Y Hansson… - Cancer Immunology …, 1984 - Springer
S Paulie, H Koho, H Ben-Aissa, Y Hansson, ML Lundblad, P Perlmann
Cancer Immunology, Immunotherapy, 1984Springer
The cellular target structures for six monoclonal antibodies raised against cultured human
bladder carcinoma cells (TCC) were investigated. The specificities of these antibodies when
tested against a large panel of cells have been described in the companion paper.
Radiolabeled cell lysates were precipitated with the different monoclonal antibodies bound
to protein A (Staphylococcus aureus) on a matrix of Sepharose beads. The precipitates were
separated by sodium dodecyl sulfate-gel electrophoresis (SDS-PAGE) and analyzed by …
Summary
The cellular target structures for six monoclonal antibodies raised against cultured human bladder carcinoma cells (TCC) were investigated. The specificities of these antibodies when tested against a large panel of cells have been described in the companion paper. Radiolabeled cell lysates were precipitated with the different monoclonal antibodies bound to protein A (Staphylococcus aureus) on a matrix of Sepharose beads. The precipitates were separated by sodium dodecyl sulfate- gel electrophoresis (SDS-PAGE) and analyzed by autoradiography. The antibodies 4B5, 7E9, and 14B11 have previously been found to react in a similar way with TCC-targets and some non-TCC tumor cells, but not with normal urothelial cells or cells of hematopoietic origin. When tested with lysates of a TCC- cell line (TCCSuP) a strong 92K band and a weak 23K band were precipitated with any one of these antibodies. These polypeptides were expressed on the cell surface and were not linked by disulfide bonds. Depletion experiments confirmed that the three antibodies recognized the same antigens. Another antibody (4E8) probably directed to a differentiation antigen present on both urothelial and melanoma cells detected two high molecular polypeptides, 190K and 170K. Antibodies from the S2C6 hybridoma, which displayed a distinct dual specificity for TCC- targets and for malignant or transformed cells of B cell origin, precipitated a 50K component from extracts of either TCC- or B cell-derived cell lines. Antibodies produced by the S2A9 hybridoma were shown to bind to a framework epitope of the HLA-A, B, C heavy chain.
Springer